Skip to main content
Log in

Is Once Weekly Administration of Antidepressants Feasible?

Experience with Fluoxetine

  • Current Opinion
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Antidepressant medications are taken daily or more frequently based on both tradition and pharmacokinetics of the drugs. However, weekly administration may be a feasible option for drugs with a long elimination half-life and flat dose-response curve. In addition to providing effective control of symptoms, it is possible that weekly administration could also benefit patients by reducing costs and minimising drug interactions and adverse effects. The selective serotonin (5-hydroxytryptamine: 5-HT) reuptake inhibitor fluoxetine appears to be a candidate for once weekly administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cushing H. Life of Sir William Osler. Vol. 1. Oxford: Clarendon Press, 1925

  2. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47: 1093–9

    Article  PubMed  CAS  Google Scholar 

  3. Thase ME, Fava M, Halbreich U, et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996; 53: 777–84

    Article  PubMed  CAS  Google Scholar 

  4. Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992; 49: 769–73

    Article  PubMed  CAS  Google Scholar 

  5. Montgomery SA, Dufour H, Brion S, et al. The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988; 153(3 Suppl.): 69–76

    Google Scholar 

  6. Montgomery SA, James D, De Ruiter M, et al. Weekly oral fluoxetine treatment of major depressive disorder. Presented at the 15th Collegium Internationale Neuro-Psychopharmacologicum Congress; 1986 Dec 14-17; Puerto Rico

  7. Van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993; 24(3): 203–20

    Article  PubMed  Google Scholar 

  8. Preskorn SH, Magnus RD. Inhibition of hepatic P-450 isoenzymes by serotonin selective reuptake inhibitors: in vitro and in vivo findings and their implications for patient care. Psychopharmacol Bull 1994: 30(2): 251–9

    PubMed  CAS  Google Scholar 

  9. Wernicke SF, Dunlop SR, Dornseif BE, et al. Low-dose fluoxetine therapy for depression. Psychopharmacol Bull 1988; 24(1): 183–8

    PubMed  CAS  Google Scholar 

  10. Beasley CM, Bosomworth JC, Wernicke JF. Fluoxetine: relationships among dose. response. adverse events, and plasma concentrations in the treatment of depression. Psychopharmacol Bull 1990; 26(1): 18–24

    PubMed  Google Scholar 

  11. Burke WJ, Hendricks SE, McArthur-Campbell DA, et al. Weekly fluoxetine controls symptoms of depression [abstract no. NR169]. American Psychiatric Association: 1995 Annual Meeting New Research Program and Abstracts. American Psychiatric Association 148th Annual Meeting; 1995 May 20-25; Miami

  12. Burke WJ, Hendricks SE, McArthur-Campbell DA, et al. Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing. Psychopharmacol Bull 1996; 32(1): 27–32

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J. Burke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burke, W.J., Hendricks, S.E. & McArthur-Campbell, D. Is Once Weekly Administration of Antidepressants Feasible?. CNS Drugs 8, 199–202 (1997). https://doi.org/10.2165/00023210-199708030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199708030-00002

Keywords

Navigation